论文部分内容阅读
在寻求急性冠状动脉综合征和卒中症状的治疗方面,患者延误是限制提供这些疾病的确定性治疗的主要因素。尽管数十年来的研究和公众教育活动一直旨在缩短患者延误时间,但大多数患者仍然不能及时求医。在本科学声明中,我们总结了以下证据：(1)证明早期治疗的益处；(2)描述患者延误问题的程度；(3)确定与患者延误及时求医有关的因素；(4)揭示当前减少患者延误措施的不足。最后,提出临床实践和今后研究的建议。
Patient delays in seeking treatment for acute coronary syndromes and stroke symptoms are a major factor limiting the definitive treatment of these diseases. Although decades of research and public education have always been aimed at reducing patient delays, most patients still can not seek medical advice on time. In our Statement of Science, we summarize the following evidence: (1) demonstrating the benefits of early treatment; (2) describing the extent of the patient’s delay problem; (3) identifying the factors associated with timely patient delay and (4) Reduce the lack of patient delay measures. Finally, put forward clinical practice and recommendations for future research.